Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 2 (KRT18P2) is a noncoding, processed pseudogene located on chromosome 21q21.1. It originates from keratin 18, a gene encoding a type I intermediate filament protein crucial for structural integrity in epithelial cells. Unlike the functional KRT18 gene, KRT18P2 does not contain an intact protein-coding sequence and does not produce a functional protein. Accordingly, it is not considered a therapeutic target, does not have a known biological function, and is not implicated directly in any disease. KRT18P2 is catalogued for genomic reference and annotation, but its existence is primarily of interest for evolutionary and genomic studies, rather than for drug discovery or biomarker development.
not applicable for pseudogenes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 2 (KRT18P2).